F Gianese

450 total citations
22 papers, 322 citations indexed

About

F Gianese is a scholar working on Cell Biology, Surgery and Internal Medicine. According to data from OpenAlex, F Gianese has authored 22 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cell Biology, 7 papers in Surgery and 7 papers in Internal Medicine. Recurrent topics in F Gianese's work include Proteoglycans and glycosaminoglycans research (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Platelet Disorders and Treatments (5 papers). F Gianese is often cited by papers focused on Proteoglycans and glycosaminoglycans research (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Platelet Disorders and Treatments (5 papers). F Gianese collaborates with scholars based in Italy, France and Australia. F Gianese's co-authors include Giancarlo Agnelli, S Coccheri, Giuseppe G. Nenci, Georges Houin, Benilde Cosmi, E Rinonapoli, L Lupattelli, L. Santoro, Enrico Arosio and M. Cortellaro and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and British journal of surgery.

In The Last Decade

F Gianese

22 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Gianese Italy 11 131 130 123 108 74 22 322
John A. Froehlich United States 11 238 1.8× 23 0.2× 118 1.0× 27 0.3× 16 0.2× 16 383
Amanda P. Waller United States 12 41 0.3× 108 0.8× 16 0.1× 69 0.6× 30 0.4× 40 465
Anthony J. Melaragno United States 14 67 0.5× 28 0.2× 11 0.1× 23 0.2× 143 1.9× 31 404
James Riddel United States 3 45 0.3× 6 0.0× 20 0.2× 51 0.5× 226 3.1× 4 312
Piotr Terlecki Poland 9 95 0.7× 6 0.0× 47 0.4× 27 0.3× 9 0.1× 48 223
M. Cazaubon France 8 184 1.4× 6 0.0× 160 1.3× 11 0.1× 10 0.1× 9 243
I.A. Zolotukhin Russia 13 455 3.5× 6 0.0× 366 3.0× 35 0.3× 10 0.1× 89 524
Myung‐Chul Yoo South Korea 7 168 1.3× 3 0.0× 29 0.2× 23 0.2× 16 0.2× 12 311
P. Tittley Canada 14 32 0.2× 9 0.1× 14 0.1× 21 0.2× 227 3.1× 27 435
Anthony F. De Giacomo United States 10 254 1.9× 69 0.5× 21 0.2× 12 0.1× 13 374

Countries citing papers authored by F Gianese

Since Specialization
Citations

This map shows the geographic impact of F Gianese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Gianese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Gianese more than expected).

Fields of papers citing papers by F Gianese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Gianese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Gianese. The network helps show where F Gianese may publish in the future.

Co-authorship network of co-authors of F Gianese

This figure shows the co-authorship network connecting the top 25 collaborators of F Gianese. A scholar is included among the top collaborators of F Gianese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Gianese. F Gianese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saivin, Sylvie, Jean‐Pierre Cambus, Claire Thalamas, et al.. (2003). Pharmacokinetics and Pharmacodynamics of Intramuscular Dermatan Sulfate Revisited. Clinical Drug Investigation. 23(8). 533–543. 4 indexed citations
2.
Arosio, Enrico, G. Ferrari, L. Santoro, F Gianese, & S Coccheri. (2001). A Placebo-controlled, Double-blind Study of Mesoglycan in the Treatment of Chronic Venous Ulcers. European Journal of Vascular and Endovascular Surgery. 22(4). 365–372. 26 indexed citations
3.
Taliani, Maria Rita, Giancarlo Agnelli, Giuseppe G. Nenci, & F Gianese. (1999). Dermatan sulphate in patients with heparin‐induced thrombocytopenia. British Journal of Haematology. 104(1). 87–89. 10 indexed citations
4.
Agnelli, Giancarlo, et al.. (1999). Dermatan Sulphate for the Prevention of Postoperative Venous Thromboembolism in Patients with Cancer. Thrombosis and Haemostasis. 82(7). 30–34. 40 indexed citations
5.
Iorio, Alfonso, et al.. (1997). Effect of Dermatan Sulphate on Activated Partial Thromboplastin Time Determined with Different Reagents. Pathophysiology of Haemostasis and Thrombosis. 27(2). 85–90. 3 indexed citations
6.
Imbimbo, Bruno P., Piérre Siè, Giancarlo Agnelli, et al.. (1994). Intramuscular Dermatan Sulfate MF701 in Patients with Hip Fracture: Relationship between Pharmacokinetics and Antithrombotic Efficacy. Thrombosis and Haemostasis. 71(5). 553–557. 7 indexed citations
7.
Cofrancesco, E., Carla Boschetti, Patrizia Leonardi, F Gianese, & M. Cortellaro. (1994). Dermatan sulphate for the treatment of disseminated intravascular coagulation (DIC) in acute leukaemia: A randomised, heparin-controlled pilot study. Thrombosis Research. 74(1). 65–75. 16 indexed citations
8.
Brister, Stephanie J., Frederick A. Ofosu, George J. F. Heigenhauser, F Gianese, & Michael R. Buchanan. (1994). Is Heparin the Ideal Anticoagulant for Cardiopulmonary Bypass? Dermatan Sulphate May Be an Alternate Choice. Thrombosis and Haemostasis. 71(4). 468–473. 10 indexed citations
9.
Gianese, F, et al.. (1993). The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure.. British Journal of Clinical Pharmacology. 35(3). 335–339. 4 indexed citations
10.
Agnelli, Giancarlo, Benilde Cosmi, F Gianese, et al.. (1992). A Randomised, Double-Blind, Placebo-Controlled Trial of Dermatan Sulphate for Prevention of Deep Vein Thrombosis in Hip Fracture. Thrombosis and Haemostasis. 67(2). 203–208. 72 indexed citations
11.
Prandoni, Paolo, et al.. (1992). Dermatan sulphate: A safe approach to prevention of postoperative deep vein thrombosis. British journal of surgery. 79(6). 505–509. 26 indexed citations
12.
Tripodi, Armando, et al.. (1991). Effects of subcutaneously administered dermatan sulfate (MF 701) on the coagulation and fibrinolytic parameters of healthy volunteers. Thrombosis Research. 62(6). 663–672. 9 indexed citations
13.
Dawes, J., J. J. F. Belch, David A. Lane, et al.. (1991). The pharmacokinetics of dermatan sulphate MF701 in healthy human volunteers.. British Journal of Clinical Pharmacology. 32(3). 361–366. 18 indexed citations
14.
Gianese, F, et al.. (1991). A survey of the clinical experience with dermatan sulfate.. PubMed. 17 Suppl 2. 199–204. 5 indexed citations
15.
Cofrancesco, E., et al.. (1990). The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and βTG/PF4 release. Thrombosis Research. 57(3). 405–414. 9 indexed citations
16.
Agnelli, Giancarlo, et al.. (1990). Human Pharmacokinetics and Pharmacodynamics of MF 701 Dermatan Sulfate Administered by Continuous Intravenous Infusion. Thrombosis and Haemostasis. 64(2). 256–259. 3 indexed citations
17.
Dol, F., Georges Houin, M Rostin, et al.. (1989). Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans. Blood. 74(5). 1577–1582. 19 indexed citations
18.
Toulon, Pierre, Martine Aiach, & F Gianese. (1989). In Vitro Study of a New Potential Antithrombotic Drug MF 701 (Dermatan Sulfate). Annals of the New York Academy of Sciences. 556(1). 486–488. 1 indexed citations
19.
Gianese, F, et al.. (1988). Dermatan sulfate as a potential antithrombotic drug.. PubMed. 72(5). 459–64. 10 indexed citations
20.
Castelli, Patrizio, et al.. (1987). Thrombosis prevention with ticlopidine after femoropopliteal thromboendarterectomy.. PubMed. 71(4). 252–5. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Froehlich Breakdown of academic impact, for papers by Amanda P. Waller Breakdown of academic impact, for papers by Anthony J. Melaragno Breakdown of academic impact, for papers by James Riddel Breakdown of academic impact, for papers by Piotr Terlecki Breakdown of academic impact, for papers by M. Cazaubon Breakdown of academic impact, for papers by I.A. Zolotukhin Breakdown of academic impact, for papers by Myung‐Chul Yoo Breakdown of academic impact, for papers by P. Tittley Breakdown of academic impact, for papers by Anthony F. De Giacomo
Rankless by CCL
2026